APEX MEDICAL XT1 CPAP, MODEL 9S-005

K070609 · Apex Medical Corp. · BZD · May 4, 2007 · Anesthesiology

Device Facts

• Record ID: K070609
• Device Name: APEX MEDICAL XT1 CPAP, MODEL 9S-005
• Applicant: Apex Medical Corp.
• Product Code: BZD · Anesthesiology
• Decision Date: May 4, 2007
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 868.5905
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

This device is intended to provide continuous positive airway pressure (CPAP) for the treatment of adult obstructive sleep apnea (OSA).

Device Story

XT1 CPAP Model 9S-005 provides continuous positive airway pressure (CPAP) to treat adult obstructive sleep apnea. Device delivers pressurized air to patient via mask interface to maintain airway patency during sleep. Used in home or clinical settings under physician prescription. Operation involves setting pressure levels to prevent airway collapse. Benefits include reduction of apnea events and improved sleep quality for patients.

Clinical Evidence

No clinical data provided; substantial equivalence determination based on device description and intended use.

Technological Characteristics

Noncontinuous ventilator (CPAP) classified under 21 CFR 868.5905, Product Code BZD. Device functions as a pressure generator for airway support.

Indications for Use

Indicated for adult patients with obstructive sleep apnea (OSA) requiring continuous positive airway pressure therapy. Prescription use only.

Regulatory Classification

Identification

A noncontinuous ventilator (intermittent positive pressure breathing-IPPB) is a device intended to deliver intermittently an aerosol to a patient's lungs or to assist a patient's breathing.

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized eagle with three stripes representing the department's mission. The text "DEPARTMENT OF HEALTH AND HUMAN SERVICES, USA" is arranged in a circular pattern around the eagle.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Mr. Alan Chang Management Representative Apex Medical Corporation No. 9, Min Sheng Street Tu-Cheng, Taipei County TAIWAN, R.O.C.

MAY - 4 2007

Re: K070609

Trade/Device Name: XT1 CPAP Model 9S-005 Regulation Number: 21 CFR 868.5905 Regulation Name: Noncontinuous Ventilator (IPPB) Regulatory Class: II Product Code: BZD Dated: April 14, 2007 Received: April 17, 2007

Dear Mr. Chang:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{1}------------------------------------------------

Page 2 - Mr. Chang

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act): 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Susan Gunner
Shi-Ling Hsu, Ph.D.

Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Apex Medical Corp. CPAP 9S-005

510(k) Premarket Notification Section D - Statement of Indications for Use

## Indications for Use

510(k) Number (if known): _ くんつて 6 6 9

Device Name: CPAP 9S-005

Indications for Use:

This device is intended to provide continuous positive airway pressure (CPAP) for the

treatment of adult obstructive sleep apnea (OSA).

Prescription Use __ x __ _ x (Part 21 CFR 801 Subpart D)

AND/OR Over-The-Counter Use (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF

NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Chl. Mda

nesthesiology, General Hospital, n Control Dantal Dos

Page 1 of

1